World leaders, civil society and global health researchers will convene at the United Nations General Assembly for arguably the most important meeting on antimicrobial resistance (AMR) this decade.
L’expertise universitaire, l’exigence journalistique
Articles sur Superbugs
Affichage de 1 à 20 de 91 articles
Personalized medicine is a promising treatment for recurrent cancer and superbugs, but it is labour-intensive and expensive, and pathways for its regulatory approval and reimbursement are complicated.
Zosurabalpin is highly effective against dangerous bacterium Crab, which can kill up to 60% of people infected with it.
The contrasting realities of antimicrobial resistance between high-income countries and low- and middle-income countries demands international co-operation to effectively fight superbugs.
Developing new antibiotics is important in the fight against antibiotic resistance. But we also need to use the antibiotics we already have much more wisely – GPs play a major role in this.
Antimicrobial resistance is an epidemic that kills close to 5 million people annually. The solutions are complex and must take into account the needs of the poor.
Researchers are desperately seeking viable alternatives to antibiotics. So what is phage therapy? And how could it help?
Scientists are racing to discover new antibiotics that can defeat these drug-resistant superbugs. So how is the newly developed antibiotic clovibactin different?
Up to 20% of Australians admitted in hospital say they have a penicillin allergy. But not everyone who thinks they’re allergic to penicillin actually is.
Resistance arises when bacteria are exposed to levels of antibiotics that don’t immediately kill them. Here’s how.
Hospitals are more risky than farms when it comes to the spread of the Klebsiella superbug.
Nice recommends faecal transplants to treat antibiotic-resistant Clostridium difficile infections. The treatment has been used in the UK since 2013.
Canada lags behind other developed countries in access to newer antimicrobials. Here’s why that matters, and what can be done about it.
A genetic trick called an integron plays an important role in helping bacteria do this.
We found a new way to revert antibiotic resistance. It involves using phage therapy to resensitise a type of bacteria to antibiotics.
Antibiotic-resistant bacteria is one of the greatest threats to public health. The bacteria are so pervasive, they’re spilling over to penguins, sea lions, wallabies and more.
Estimating the cost of antibiotic resistance to economies and health-care systems is fraught with difficulty, but new research says Australia will be hit harder than we think.
Superbugs spread through the environment – and it needs urgent attention.
A CSIRO survey has found many people are confused about common infections, believing antibiotics can treat colds, flu and other viruses. This could fuel a dangerous rise in drug-resistant superbugs.
Antibiotic resistant superbugs kill 32 plane-loads of people a week. We can all help fight back
The Conversation, CC BY48 Mo (download)
Antibiotic resistant infections already kill about 700,000 people globally every year. While scientists are racing to find new ways to fight superbugs, there's one thing you can do, too.
Les contributeurs les plus fréquents
-
Prof. Institute for Molecular Bioscience, The University of Queensland
-
Professor, The University of Queensland
-
Professor of Infectious Diseases and Microbiology, Australian National University
-
Professor of Nursing and Health Services Research, Avondale College of Higher Education
-
Infectious Diseases Physician, Senior Lecturer, James Cook University and, The University of Queensland
-
Professor of Infectious Diseases, Monash University
-
Professor at ANU Medical School; Senior Staff Specialist Infectious Diseases; General Physician, Australian National University
-
Professor of Biocchemistry and Biomedical Sciences, McMaster University
-
Research Fellow in Microbiology, University of Glasgow
-
Professor of Ecosystems Engineering, Newcastle University
-
Professor of Molecular Evolution, Macquarie University
-
Professor, The Peter Doherty Institute for Infection and Immunity
-
Reader in Biology, University of Leicester
-
Senior Research Officer in the Institute for Molecular Bioscience, The University of Queensland
-
Professor of Sociology & Director, Sydney Centre for Healthy Societies, University of Sydney
